Compare HTCR & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HTCR | VTAK |
|---|---|---|
| Founded | 2009 | 2002 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4M | 3.0M |
| IPO Year | 2022 | 2018 |
| Metric | HTCR | VTAK |
|---|---|---|
| Price | $3.07 | $0.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 94.5K | 52.5K |
| Earning Date | 05-14-2026 | 08-11-2026 |
| Dividend Yield | ★ 87.84% | N/A |
| EPS Growth | ★ 414.29 | 89.53 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $30,407,229.00 | $442,000.00 |
| Revenue This Year | $123.26 | $1,170.33 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 39.19 | ★ 3057.14 |
| 52 Week Low | $0.15 | $0.15 |
| 52 Week High | $3.97 | $4.31 |
| Indicator | HTCR | VTAK |
|---|---|---|
| Relative Strength Index (RSI) | 48.47 | 46.26 |
| Support Level | $2.80 | $0.88 |
| Resistance Level | $3.86 | $1.16 |
| Average True Range (ATR) | 0.39 | 0.10 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 11.34 | 35.29 |
HeartCore Enterprises Inc is a software development company providing solutions for digital transformation (DX). It develops, sells, and maintains CMS and CXM platforms using digital marketing technology, RPA, process mining solutions, myInvenio and Apromore, task mining solution CONTROLIO, and 3D-VR services including Matterport and VR360. The company also provides management consulting, education, services, and support to help customers succeed with the CXM Platform. It operates through two business units, the CX division for customer experience management and the DX division for digital transformation, which provides robotics process automation, process mining, and task mining. Its products include VR360, myInvenio, Apromore, and others, with maximum revenue from the United States.
Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.